Stay updated on MPS IIIB Enzyme Replacement Clinical Trial
Sign up to get notified when there's something new on the MPS IIIB Enzyme Replacement Clinical Trial page.

Latest updates to the MPS IIIB Enzyme Replacement Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedLocations section updated to include California as a study site; the California Locations entry was removed. The HHS Vulnerability Disclosure link in the footer was removed in this revision.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe changes are limited to metadata about publication listings and page revision notes, which do not alter the study content, eligibility criteria, or reported results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThe notice about a lapse in government funding and the associated operating-status information has been removed.SummaryDifference0.4%

- Check71 days agoChange DetectedThe Study Details page layout has been updated with formatting changes, with no new data or eligibility adjustments.SummaryDifference0.4%

- Check100 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

- Check107 days agoChange DetectedUpdate includes standardizing the disease name to Mucopolysaccharidosis type 3B and upgrading the revision from v3.0.2 to v3.1.0 (no new substantive content beyond terminology and versioning).SummaryDifference0.2%

Stay in the know with updates to MPS IIIB Enzyme Replacement Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MPS IIIB Enzyme Replacement Clinical Trial page.